Home LiteratureArticle Details
PMID: 1995942 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Direct measurement of soluble CD4 binding to human immunodeficiency virus type 1 virions: gp120 dissociation and its implications for virus-cell binding and fusion reactions and their neutralization by soluble CD4.

Journal of virology ·Vol. 65 ·No. 3 ·1991-03-00 ·Pages 1133-40

Moore JP, McKeating JA, Norton WA, Sattentau QJ

Abstract

We have analyzed the binding of soluble CD4 (sCD4) to human immunodeficiency virus type 1 (HIV-1) virions (isolates IIIB and RF) at 4 and 37 degrees C by using a combination of gel exclusion chromatography and enzyme-linked immunosorbent assay detection systems. The sCD4 binding curve at 37 degrees C indicates that the affinity of the interaction of sCD4 with gp120 on the virion surface is indistinguishable from the affinity of sCD4 for the equivalent concentration of soluble gp120. At 4 degrees C, however, the affinity of sCD4 for virion-bound gp120 but not for soluble gp120 is reduced by about 20-fold. Binding of sCD4 (greater than 0.2 microgram/ml) to virions at 37 degrees C but not 4 degrees C induces the rapid dissociation of a major proportion of gp120 from gp41 on the virion surface. This dissociation requires occupancy by sCD4 of multiple (probably two) binding sites on a gp120-gp41 oligomer. At 37 degrees C there are two components to the neutralizing action of sCD4 on HIV-1; reversible, competitive inhibition at low sCD4 concentrations (less than 0.2 microgram/ml) and essentially irreversible inhibition due to gp120 loss at higher sCD4 concentrations. At 4 degrees C, sCD4 neutralizes HIV infectivity by competitive inhibition alone. These findings may have implications for the HIV-CD4+ cell binding and fusion reactions and the mechanism by which sCD4 blocks infectivity.

MeSH Terms
CD4 Antigens/immunology Cell Line Enzyme-Linked Immunosorbent Assay HIV Envelope Protein gp120/immunology HIV-1/immunology Humans Kinetics Neutralization Tests Protein Binding Recombinant Proteins/immunology Virion/immunology
Chemicals
CD4 Antigens HIV Envelope Protein gp120 Recombinant Proteins
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Moore J P
Chester Beatty Laboratories, Institute of Cancer Research, London, United Kingdom.
McKeating J A
Norton W A
Sattentau Q J
References (37)
37 references, click to expand
  1. Human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus env proteins possess a functionally conserved assembly domain.
    J Virol. 1990 Jul;64(7):3537-40 PMID: 2352332
  2. Characterization of recombinant gp120 and gp160 from HIV-1: binding to monoclonal antibodies and soluble CD4.
    AIDS. 1990 Apr;4(4):307-15 PMID: 2190605
  3. High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates.
    Proc Natl Acad Sci U S A. 1990 Sep;87(17):6574-8 PMID: 2395859
  4. The human immunodeficiency virus type 1 envelope glycoprotein precursor acquires aberrant intermolecular disulfide bonds that may prevent normal proteolytic processing.
    Virology. 1990 Dec;179(2):827-33 PMID: 2238472
  5. Dissociation of gp120 from HIV-1 virions induced by soluble CD4.
    Science. 1990 Nov 23;250(4984):1139-42 PMID: 2251501
  6. Morphometric analysis of recombinant soluble CD4-mediated release of the envelope glycoprotein gp120 from HIV-1.
    AIDS Res Hum Retroviruses. 1990 Oct;6(10):1209-12 PMID: 2252640
  7. Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization.
    J Virol. 1991 Feb;65(2):852-60 PMID: 1898972
  8. Enhancement of soluble CD4-mediated HIV neutralization and gp 120 binding by CD4 autoantibodies and monoclonal antibodies.
    AIDS Res Hum Retroviruses. 1990 Nov;6(11):1273-9 PMID: 2078408
  9. Differences in the interaction of HIV-1 and HIV-2 with CD4.
    J Acquir Immune Defic Syndr. 1990;3(7):649-57 PMID: 1693676
  10. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.
    Nature. 1984 Dec 20-1985 Jan 2;312(5996):763-7 PMID: 6096719
  11. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV.
    Nature. 1984 Dec 20-1985 Jan 2;312(5996):767-8 PMID: 6083454
  12. Loss of envelope antigens of HTLV-III/LAV, a factor in AIDS pathogenesis?
    Lancet. 1985 Nov 2;2(8462):1016-7 PMID: 2865493
  13. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain.
    Cell. 1986 Nov 7;47(3):333-48 PMID: 3094962
  14. Shedding and interspecies type sero-reactivity of the envelope glycopolypeptide gp120 of the human immunodeficiency virus.
    J Gen Virol. 1986 Nov;67 ( Pt 11):2533-8 PMID: 2431105
  15. Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor.
    Cell. 1987 Sep 11;50(6):975-85 PMID: 2441877
  16. Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen.
    Science. 1987 Dec 18;238(4834):1704-7 PMID: 3500514
  17. A soluble CD4 protein selectively inhibits HIV replication and syncytium formation.
    Nature. 1988 Jan 7;331(6151):78-81 PMID: 2829023
  18. A soluble form of CD4 (T4) protein inhibits AIDS virus infection.
    Nature. 1988 Jan 7;331(6151):82-4 PMID: 3257544
  19. Soluble CD4 molecules neutralize human immunodeficiency virus type 1.
    Nature. 1988 Jan 7;331(6151):84-6 PMID: 2829024
  20. The CD4 antigen: physiological ligand and HIV receptor.
    Cell. 1988 Mar 11;52(5):631-3 PMID: 2830988
  21. Neutralizing monoclonal antibodies to the AIDS virus.
    AIDS. 1988 Feb;2(1):25-9 PMID: 2451922
  22. The human and simian immunodeficiency viruses HIV-1, HIV-2 and SIV interact with similar epitopes on their cellular receptor, the CD4 molecule.
    AIDS. 1988 Apr;2(2):101-5 PMID: 2454642
  23. Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4.
    J Virol. 1988 Nov;62(11):4195-200 PMID: 2845130
  24. Characterization of GP120 binding to CD4 and an assay that measures ability of sera to inhibit this binding.
    J Immunol. 1988 Dec 15;141(12):4181-6 PMID: 3264307
  25. Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells.
    Nature. 1989 Jan 26;337(6205):368-70 PMID: 2536142
  26. An enzyme-linked immunosorbent assay for antibodies to the envelope glycoproteins of divergent strains of HIV-1.
    AIDS. 1989 Mar;3(3):155-63 PMID: 2540772
  27. Highly efficient neutralization of HIV with recombinant CD4-immunoglobulin molecules.
    Nature. 1989 May 4;339(6219):68-70 PMID: 2541344
  28. Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1.
    J Virol. 1989 Jun;63(6):2674-9 PMID: 2786089
  29. A general model for the transmembrane proteins of HIV and other retroviruses.
    AIDS Res Hum Retroviruses. 1989 Aug;5(4):431-40 PMID: 2788443
  30. Studies with crosslinking reagents on the oligomeric structure of the env glycoprotein of HIV.
    Virology. 1989 Sep;172(1):367-9 PMID: 2672564
  31. Characterization of in vitro inhibition of human immunodeficiency virus by purified recombinant CD4.
    J Virol. 1989 Oct;63(10):4370-5 PMID: 2550671
  32. Evaluation of human and simian immunodeficiency virus plaque and neutralization assays.
    J Gen Virol. 1989 Dec;70 ( Pt 12):3327-33 PMID: 2575137
  33. Recombinant soluble CD4 therapy in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase I-II escalating dosage trial.
    Ann Intern Med. 1990 Feb 15;112(4):247-53 PMID: 2297203
  34. The safety and pharmacokinetics of recombinant soluble CD4 (rCD4) in subjects with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase 1 study.
    Ann Intern Med. 1990 Feb 15;112(4):254-61 PMID: 2297204
  35. Biological properties of a CD4 immunoadhesin.
    Nature. 1990 Apr 12;344(6267):667-70 PMID: 1970124
  36. Simple methods for monitoring HIV-1 and HIV-2 gp120 binding to soluble CD4 by enzyme-linked immunosorbent assay: HIV-2 has a 25-fold lower affinity than HIV-1 for soluble CD4.
    AIDS. 1990 Apr;4(4):297-305 PMID: 2190604
  37. HIV requires multiple gp120 molecules for CD4-mediated infection.
    Nature. 1990 Jul 19;346(6281):277-9 PMID: 2374593
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1991-03-00
Pages
1133-40
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC239879
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]